+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Combination of radiation therapy and interferon alpha-2b in patients with advanced cervical carcinoma: a pilot study



Combination of radiation therapy and interferon alpha-2b in patients with advanced cervical carcinoma: a pilot study



International Journal of Gynecological Cancer 9(5): 401-405



Carcinoma of the uterine cervix is the most frequent malignancy in women in developing countries. Based on the possible synergistic effect of the combination of interferon and radiotherapy, a clinical trial was conducted in patients with advanced cervical cancer. The objective was to evaluate the efficacy and security of such a therapeutic approach. This prospective phase II trial was done at the Instituto Nacional de Cancerología in Mexico City. The study included 17 consecutive patients with previously untreated squamous cell cervical cancer, clinical stages III and IV, and tumor mean size of 9.7 cm. The patients received radiotherapy and interferon alpha-2b at a dose of 5 x 106 IU/m2 3 times a week for 6 weeks. Eleven (64%) complete responses were obtained among these patients. Long-term survival was observed in 4 patients (24%) who achieved complete response and are alive after 10 years of follow-up. Immediate toxicity was mild. Late toxicity included the development of proctitis in 13 patients, colostomy was performed in 3 (23%) of them. Our results indicate that the combination of radiotherapy and this cytokine is an active therapy for squamous cell carcinoma of the uterine cervix.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 045567087

Download citation: RISBibTeXText

PMID: 11240801


Related references

Phase III randomized pilot study comparing interferon alpha-2b in combination with radiation therapy versus radiation therapy alone in patients with stage III-B carcinoma of the cervix. International Journal of Gynecological Cancer 13(2): 164-169, 2003

Clinical pilot study of methotrexate-5-fluorouracil, cisplatin, and interferon alpha-2B combination treatment for patients with advanced hepatocellular carcinoma. Hepatology 24(4 Part 2): 592A, 1996

GM-CSF in combination with IL2 and alpha-interferon in the treatment of advanced renal cell carcinoma - A pilot study. Annals of Hematology 73(Suppl. 2): A76, 1996

Pilot study of combination chemotherapy of S-1, a novel oral DPD inhibitor, and interferon-alpha for advanced hepatocellular carcinoma with extrahepatic metastasis. Cancer 112(8): 1765-1771, 2008

Phase I-II study of 5-fluorouracil, recombinant interferon alpha2a, and cisplatin in combination with external beam radiation therapy followed by surgery in patients with locally advanced carcinoma of the esophagus. American Journal of Clinical Oncology 22(4): 391-395, 1999

Alpha interferon cddp pep and 5 fu combination therapy for patients with advanced renal cell carcinoma. Journal of Cancer Research & Clinical Oncology 116(Suppl. Part 1): 533, 1990

Results of a phase 3, randomized study of patients with advanced renal cell carcinoma (RCC) and poor prognostic features treated with temsirolimus, interferon-alpha or the combination of temsirolimus plus interferon-alpha. 2007

Is interferon-alpha and retinoic acid combination along with radiation superior to chemo-radiation in the treatment of advanced carcinoma of cervix?. Indian Journal of Cancer 43(2): 54-59, 2006

A phase I pilot study of pelvic radiation and alpha-2A interferon in patients with locally advanced or recurrent rectal cancer. International Journal Of Radiation Oncology Biology Physics. 37(2): 297-303, 1997

Phase ii study of a combination therapy with human interferon alpha vinblastine tamoxifen in the advanced renal cell carcinoma. Journal of Cancer Research & Clinical Oncology 111(Suppl.): S41, 1986

Combination alpha-interferon and lamivudine therapy for alpha-interferon-resistant chronic hepatitis B infection: Results of a pilot study. Journal of Hepatology 28(6): 923-929, 1998

A pilot trial of combination cisplatin, 5-fluorouracil and interferon-alpha in the treatment of advanced esophageal carcinoma. ChemoTherapy 48(4): 211-216, 2002

Peginterferon alpha-2a combination therapies in chronic hepatitis C patients who relapsed after or had a viral breakthrough on therapy with standard interferon alpha-2b plus ribavirin: a pilot study of efficacy and safety. Digestive Diseases and Sciences 50(4): 719-726, 2005

RTOG 0417: efficacy of bevacizumab in combination with definitive radiation therapy and cisplatin chemotherapy in untreated patients with locally advanced cervical carcinoma. International Journal of Radiation Oncology Biology Physics 88(1): 101-105, 2014

Combination therapy with 5-fluorouracil (5-FU), cisplatin (CDDP) and interferon alpha-2B (IFN alpha-2B) for advanced renal cell carcinoma. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(12): 1689-1691, 1996